Using Haloperidol as an Antiemetic in Palliative Care: Informing Practice Through Evidence From Cancer Treatment and Postoperative Contexts

REFERENCES

• Settle EC, Ayd FJ. Haloperidol: a quarter century of experience. J Clin Psychiatry. 1983;44:440–448.
   PubMed Web of Science ®Google Scholar
• Janssen PAJ, Niemegeers CJE. Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone: II. Inhibition of apomorphine vomiting in dogs. Arzneimittelforschung. 1959;9:765–767.
   PubMed Web of Science ®Google Scholar
• Depoortère R, Barret-Grévoz C, Bardin L, Newman-Tancredi A. Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds. Eur J Pharmacol. 2008;597:34–38.
   PubMed Web of Science ®Google Scholar
• Hsu WH, Schaffer DD, Dyer DC. The emetic effect of B-HT 920 and apomorphine in the dog: antagonism by haloperidol. Life Sci. 1986;39:1021–1026.
   PubMed Web of Science ®Google Scholar
• Osinski MA, Uchic ME, Seifert T, Dopamine D2, but not D4, receptor agonists are emetogenic in ferrets. Pharmacol Biochem Behav. 2005;81:211–219.
   PubMed Web of Science ®Google Scholar
• De Lima L, Doyle D. The International Association for Hospice and Palliative Care list of essential medicines for palliative care. J Pain Palliat Care Pharmacother. 2007;21:29–36.
   PubMedGoogle Scholar
• Darmani NA, Ray AP. Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting. Chem Rev. 2009;109:3158–199.
   PubMed Web of Science ®Google Scholar
• Mannix KA. Palliation of nausea and vomiting. In Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press; 2004:459–468.
   Google Scholar
• Irving CB, Adams CE, Lawrie S. Haloperidol versus placebo for schizophrenia. Cochrane Database Sys Rev. 2006;(4):CD003082.
   Google Scholar
• Critchley P, Plach N, Grantham M, Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systemic review. J Pain Symptom Manage. 2001;22:631–633.
   PubMed Web of Science ®Google Scholar
• Glare P, Pereira G, Kristjanson L, Stockler M, Tattersall M. Systemic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer. 2004;12:432–440.
   PubMed Web of Science ®Google Scholar
• Perkins P, Dorman S. Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database Sys Rev. 2009;(2):CD006271.
   Google Scholar
• Keeley PW. Nausea and vomiting in people with cancer and other chronic diseases. Clin Evid (online). 2009;pii:2406.
   PubMedGoogle Scholar
• Büttner M, Walder B, von Elm E, Tramèr MR, Phil D. Is low-dose haloperidol a useful antiemetic? A meta-analysis of published and unpublished randomized trials. Anesthesiology. 2004;101:1454–1063.
   PubMed Web of Science ®Google Scholar
• Neidhart JA, Gagen M, Young D, Wilson HE. Specific antiemetics for specific cancer chemotherapeutic agents: haloperidol versus benzquinamide. Cancer. 1981;47: 1439–1443.
   PubMed Web of Science ®Google Scholar
• Cole DR, Duffy DF. Haloperidol for radiation sickness: control of associated nausea, vomiting, and anorexia. N Y State J Med. 1974;74:1558–1562.
   PubMedGoogle Scholar
• Tramèr MR. A rationale approach to the control of postoperative nausea and vomiting: evidence from systematic reviews II: recommendations for prevention and treatment, and research agenda. Acta Anaesthesiol Scand. 2001;45:14–19.
   PubMed Web of Science ®Google Scholar
• Lee Y, Wang PK, Lai HY, Yang YL, Chu CC, Wang JJ. Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting. Can J Anesth. 2007;54:349–354.
   PubMed Web of Science ®Google Scholar
• Rosow CE, Haspel KL, Smith SE, Grecu L, Bittner EA. Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting. Anesth Analg. 2008;106:1407–1409.
   PubMed Web of Science ®Google Scholar
• Wang TF, Liu YH, Chu CC, Shieh JP, Tzeng JI, Wang JJ. Low-dose haloperidol prevents post-operative nausea and vomiting after ambulatory laparoscopic surgery. Act Anaesthesiol Scand. 2008;52:280–284.
   PubMed Web of Science ®Google Scholar
• Chaparro LE, Gallo T, Gonzalez NJ, Rivera MF, Peng PW. Effectiveness of combined haloperidol and dexamethasone versus dexamethasone only for postoperative nausea and vomiting in high-risk day surgery patients: a randomized blinded trial. Eur J Anaesthesiol. 2010;27:192–195.
   PubMed Web of Science ®Google Scholar
• Feng PH, Chu KS, Lu IC, Haloperidol plus ondansetron prevents postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Acta Anaesthesiol Taiwan. 2009;47:3–9.
   PubMedGoogle Scholar
• Grecu L, Bittner EA, Kher J, Smith S, Rosow CE. Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting. Anesth Analg. 2008;106:1410–1413.
   PubMed Web of Science ®Google Scholar
• Chu CC, Shieh JP, Tzeng JI, The prophylactic effect of haloperidol plus dexamethasone on postoperative nausea and vomiting in patients undergoing laparoscopically assisted vaginal hysterectomy. Anesth Analg. 2008;106:1402–1406.
   PubMed Web of Science ®Google Scholar
• Hardy JR, O'Shea A, White C, Gilshenan K, Welch L, Douglas C. The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. J Pain Symptom Manage. 2010;40:111–116.
   PubMed Web of Science ®Google Scholar
• Kennett A, Hardy J, Shah S, A'Hern R. An open-label study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2005;13:715–721.
   PubMed Web of Science ®Google Scholar
• Jha SK, Vijayalakshmi P, Karki R, Goli D. Formulation and evaluation of melt-in-mouth tablets of haloperidol. Asian J Pharm. 2008;2:255–260.
   Google Scholar
• Sadashivaiah R, Dinesh BM, Patil UA, Desai BG, Raghu KS. Design and in vitro evaluation of haloperidol lactate transdermal patches containing ethyl cellulose-povidone as film formers. Asian J Pharm. 2008;2:43–49.
   Google Scholar